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ABSTRACT
Total hip and knee replacement surgery using
metal alloy devices is common. Type IV allergic
reactions to these implants occur, though
infrequently. While uncommon, peri-implant
metal allergic reactions may cause significant
morbidity for the affected individual—
including aseptic loosening, pseudotumor
formation and frank device failure. It is
challenging to predict who will have these
reactions, even in those with established
pre-implant metal allergy. At this time, the
scientific literature clearly supports few
conclusions. Despite this, we believe several
conclusions can be made: routine pre-implant
testing in asymptomatic individuals is not
indicated; listen to patient’s concerns about
metal allergy if the concern arises; patch testing
is probably the best pre- and post-implant
screening test; post-implantation testing is
controversial and even positive LTT or patch
test does not definitively diagnose morbidity
from a metal allergy; and complete recovery
following revision placement of an
immunologically inert device is diagnostic.
More research is needed to scientifically
approach this issue.
Keywords: Metal allergy; Patch testing;
Orthopedic implants
INTRODUCTION
The use of metals in orthopedics is widespread,
and there has been increasing concern with
regards to the possibility of developing
cutaneous and systemic hypersensitivity
reactions to constituent metals in implant
devices. Although hypersensitivity reactions to
metals are not common, they require
evaluation and management when they do
occur. Regrettably, there is an ostensible lack
of accord in the field on the appropriate steps to
evaluate, diagnose and manage patients with
suspected metal hypersensitivity reactions. This
review aims to explore the existing literature on
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hypersensitivity reactions to metallic implants
in orthopedic surgery and, in particular,
highlight the recent debate surrounding
appropriate pre- and post-implantation testing.
In the United States, approximately 5.2
million total knee replacements were
performed from 2000 to 2010 [1] and these
may double by 2020 [2]. For patients over
45 years old, total hip replacements more than
doubled, with 310,800 procedures being
performed in 2010 [1]. The total incidence of
total shoulder arthroplasty has also been
steadily increasing, to 27,000 in 2008 [3].
Orthopedic implants are composed of nickel,
cobalt, chromium, molybdenum, zirconium
and/or titanium alloys, while stainless steel is
used in fixed orthopedic devices such as
screws/plates [4, 5, 30]. As a cause of
complication after joint replacement, metal
allergy was first reported in 1966, with slowly
increasing awareness and reported incidence
[6–10]. While the association between metal
implant failure and allergy is well documented,
it remains a phenomenon that is relatively
unpredictable, poorly understood and highly
debated [11–13].
Skin reactions caused by MHR include
dermatitis reactions adjacent to and regionally
adjacent to the implant site, generalized
dermatitis, as well as erythema, generalized
urticaria and cutaneous vasculitis. Reactions
occur following implantation of static
implants as well as dynamic prostheses
[14–19]. Other adverse reactions including
device failure, chronic inflammation, pain,
loosening of joint prostheses or re-stenosis of
cardiac stents can also occur [20]. In some cases,
metallosis (metallic staining of the surrounding
tissue), excessive periprosthetic fibrosis and
muscular necrosis have also been reported
[21–23].
With an aging population, clarifying the
association between metal hypersensitivity
reactions and implant failures bears enormous
repercussions for health care costs, and avoids
unnecessary morbidity in patients [24]. The lack
of clear evidence-based clinical guidance in this
area creates a potential breeding ground for
unwarranted lawsuits, particularly when
patients with self–reported metal allergies
pre-implantation allege inadequate
pre-operative allergy assessment [25].
Consequently, the possibility of being
entangled in needless litigation provides a
strong driving force for seeking clarification
and consensus in the field. It is worth noting
that the following discussion is based on
previously conducted studies, and does not
involve any new studies of human or animal




The literature regarding reactions following hip
arthroplasty shows conflicting research, and the
extent to which metal sensitivity affects
implant lifespan and longevity remains
debated, without clear evidence-based
guidelines. On the one hand, a case–control
study (356 cases/712 controls) reported no
increase in the risk of total hip arthroplasty
(THA) revision in patients with cases with metal
allergy, and metal allergy risk was not elevated
after THA [26]. Unfortunately, this is not
definitive. On the other hand, there are
multiple authors reporting opposite data,
though the patient groups are smaller. In one
series examining 165 patients following
orthopedic implant, patients with osteolysis
adjacent to the implant had cobalt allergy at a
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significantly higher rate when compared to
controls [27]. Other studies also report
increased metal reactions in cases with device
loosening/prosthetic failure as well as those
undergoing surgery for revision of a failed
implant [28, 29]. Hallab’s literature review in
2001 found a metal allergy prevalence of*25%
in patients with well-functioning THA and 60%
in those with poorly functioning or failed
implants [30]. Histopathological examination
of periprosthetic tissue supports the correlation
between wear particles leading to metal allergy
and subsequent implant failure [31–37].
Unsurprisingly, studies for total knee
arthroplasty have also not been wholly
consistent. A prospective examination in
patients following total knee arthroplasty (TKA)
showed metal allergy by patch test was often
seen in those with aseptic loosening (59%)
versus stable prosthesis (48%) versus controls
without prior orthopedic device implantation
(20%) [38]. Individuals reporting a prior history
of metal reactions before device implantation
were four times more likely to develop implant
failure [39]. A lymphocyte stimulation test
before implantation of a chromium-containing
device in those positive for chromium increased
the risk of post-implant eczema [39].
Having said that, metal hypersensitivity
reactions following TKA are rare—the exact
prevalence of MHR is unknown but estimates
ranges from 0 to 5% of implanted devices [20].
Common sources of morbidity must thus be
ruled out before a diagnosis of metal allergy is
made. Pain and other symptoms such as
instability, implant loosening or malrotation
and referred or chronic regional pain are more
likely caused by infection [40]. A correlation
with metal allergy and device failure is not
certain. A cohort study of 127 patients with 161
TKA compared to 161 control knee arthroplasty
revealed that those with patch test positives to
metal had similar complication, reoperation or
revision rates when compared to those without
allergy/matched controls [41]. Rates of
post-operative pain were similar in those with
metal allergy determined by patch testing,
compared to control patients. In a separate
study, patients receiving a metal TKA showed
no increase in joint loosening in those with
metal allergy prior to implant as determined by
patch testing [42]. Another author concluded
that there was no evidence of implant failure
due to metal allergy [43]. However,
patient-reported allergy was associated with
decreased functional outcomes after TKA and
poorer scoring of mental health after THA [44].
Although there are multiple studies for total
hip and knee replacements, unfortunately there
is no definitive research that reports a link
between metal allergy and morbidity following
shoulder arthroplasty [4].
There is thus extensive literature on both
sides that asserts or renounces a correlation
between metal hypersensitivity reaction and
metallic implant failure, which only serves to
add to the existing confusion. What is clear,
however, is that even if a correlation is purported
to exist, none of the authors are able to
conclusively report the direction of causation.
It remains unknown whether implants fail or
function poorly due to a pre-existing metal
hypersensitivity, or that secondary sensitization




Given that there is no clear conclusion on the
link between metal allergy and implant failure,
it logically follows that there is a similar lack of
consensus on the approach to the testing and
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management of patients. The crucial question
at hand is whether there is a need to carry out
screening prior to implanting metal devices. If
screening is needed, what is the most effective
determination of metal allergy: epicutaneous
patch testing, a lymphocyte transformation test
or a self-reported history of metal reactions? In
addition, how should we tailor the
pre-implantation management plan for those
who test positive? Should hypoallergenic alloys,
with which surgeons may be less familiar and
are more expensive, be used? What about the
management plan for patients with suspected
metal hypersensitivity post-implantation? This
paper aims to answer each question in turn.
Is there a need for pre-implant testing?
Routine pre-implant screening or testing prior
to surgery is not indicated, and opinions
regarding the appropriate patients to test prior
to surgery are controversial. There are no
scientific or expert agreements on whether
metal hypersensitivity reactions cause joint
morbidity or failure following implant, and
thus there is also no agreement on which
patients require pre-surgical allergy evaluation.
A cohort study of 127 patients with 161 TKA
(56 patients with patch test positives) versus
161 matched control TKAs without known
metal allergy history or positive patch testing
were followed over a period of 5.3 years [41].
Most interestingly, those with patch test
positives had similar reoperation, revision or
complication rates in comparison to those with
a normal skin patch testing as well as matched
controls. Post-operative pain was not different
between any of the groups. In view of the
findings of the study, skin patch testing showed
little value for predicting the clinical outcomes
and was not recommended as a guide for
implant alloy choice. A recent review lends
support to the stance that pre-implantation
testing is not routinely needed: the review
acknowledged the presence of an association
between implant failure and metal
hypersensitivity, but concludes that the
absence of a casual relationship means that
the use of ‘‘hypoallergenic’’ implants cannot be
justified [43]. Other studies advocate the view
that pre-implantation testing is unhelpful and
of minimal benefit. For instance, Lachiewicz
et al. proposed that pre-implantation screening
prior to TKA is not necessary and that metal
allergy post-TKA should only be diagnosed after
all other possibilities are excluded [40].
A group of 18 patients with pre-implant
confirmed nickel allergy were followed for
6.3 years following implantation of a
nickel-containing device. None of these
patients developed cutaneous or systemic signs
of metal hypersensitivity [45]. In another study
of 50 patients following TKA, 32% had positive
skin patch tests to the metal constituents of the
device (n = 16), but there was no correlation
between allergy and loosening or other
prosthesis morbidity [42]. At this time, there
are no definitive studies supporting any
diagnostic test for routine pre-implant
screening.
While these studies are not supportive of
pre-implant metal allergy evaluation, it is also
still important to consider patient history of
possible metal allergy when making an implant
choice prior to surgery. A patient’s
psychological status has strong influences on
their clinical outcomes [46]. Patient reports of
metal allergy prior to implantation were
associated with poorer functional outcomes
(TKA) and mental health scores (THA) [44].
Similar findings have been reported, finding
that patient-reported allergies are a surrogate for
mental health factors that lead to increased
postoperative morbidity, and poorer functional/
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psychosocial outcomes [47–49]. In a study of
459 THA or TKA patients reporting C4 allergies,
they had decreased improvement and
functional outcomes following surgery when
compared to those with fewer allergies [50]. A
strong predictor of post-operative satisfaction
following TKA is whether or not the surgeon
met the patient’s pre-operative expectations
[51]. Thus, clear communication and making
an effort to define patient expectations is
important. Defining metal allergy status is one
of many factors necessary to building a unique
management plan for the individual. In some
cases, it may be beneficial and indicated to use
an appropriate allergen-free implant to
eliminate patient worry as a potential source
of post-operative pain in those reporting
clinical metal reactions [44].
The Danish experience as reported by
Thyssen advises against routine pre-surgery
patch testing unless there is a patient or
clinical history of metal reactions ‘‘of a
magnitude sufficient to cause concern to the
patient or the doctor’’ [52]. In Sweden,
‘‘virtually no such patients are evaluated’’ [53].
In the United Kingdom, a Delphi Analysis of
orthopedic surgeons reported that standard
cobalt chromium/stainless steel devices should
be implanted regardless of the patient’s metal
allergy status [54]. In Germany, a consensus
group pragmatically suggests using titanium
alloys for any patient self-reporting metal
allergy. No pre-implant testing was
recommended [55]. Earlier perspectives from
the United States were from Granchi and Reed,
both suggesting patch testing prior to surgery in
patients reporting a clinical history or metal
sensitivity [56, 57]. Recently, the American
Contact Dermatitis Society (ACDS) published a
consensus opinion regarding metal
hypersensitivity reactions to implanted
devices. Routine pre-implant testing is not
recommended. In those rare patients
self-reporting metal reactions on the skin,
evaluation is suggested but not mandatory [58].
In a survey performed at the European
Society of Contact Dermatitis (ESCD) and
subsequently the ACDS meetings, 54% of
respondents considered patch testing prior to
surgery indicated for those individuals
reporting moderate or severe rashes after metal
contact. For those not agreeing with
preoperative testing, 38% considered a
titanium-based alloy an acceptable alternative
[59]. Schalock and colleagues recommend a
thoughtful and custom approach to
pre-implant metal allergy: when the patch test
is positive, other factors must still be taken into
account, such as choosing the device that will
be the best functional and durable implant [60].
Ultimately, it is up to the patient and surgeon to
decide the ‘best’ and most appropriate device.
Which Test is Preferred Pre-Implantation?
If pre-implantation testing is needed, the
question that follows is which test would be
most appropriate? Determining delayed-type
hypersensitivity to metals can be done via two
routes: by skin patch testing or through a blood
test such as the lymphocyte transformation test
(LTT) or leukocyte migration inhibition test.
The patch test is performed on the skin and
is simple to perform, widely available and offers
a wide variety of possible testing when
compared to the LTT [61]. Intradermal testing
is rarely used due to false positive reactions with
metal allergens [59, 62–66]. The LTT is a
measurement of lymphocyte proliferation in
the presence and absence of a potential
allergen. The patient’s lymphocytes are taken
from peripheral blood and incubated for 7 days,
with and without the allergen presence. The
result is reported as a stimulation index,
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comparing the reactions. In the leukocyte
migration inhibition test, mixed population
leukocyte migration activity is measured in the
presence of antigen. If the result is positive,
migration is faster in non-allergic individuals
[30].
The patch test is considered the gold
standard for detecting systemic type IV
hypersensitivity reactions in the opinion of
dermatologists. In a survey of the ACDS and
EACD members, 83% of respondents
considered the patch test to be the diagnostic
test of choice for evaluation of metal allergy.
Only 12% of dermatologist commonly used the
LTT [59, 67]. Orthopedic surgeons have
different views of metal allergy and the
necessity of testing. Their general opinion is
that there is not a relevant correlation between
patch testing on the skin and the immunologic
responses in and around the bone–implant
interface [68]. This reluctance may in fact be
correct, since the relationship between actual
skin reactions in response to implanted metal
allergy as well as peri-implant morbidity
continues to be unclear [69]. Skin exposure is
not the same as the constant exposure
experienced in the closed subcutaneous
environment adjacent to the metallic
implant. The dendritic cells present similar,
but not the same. It is possible that the patch
test only partially reproduces this peri-implant
environment [70, 71]. In the skin, the
Langerhans cells are the primary
antigen-presenting cell, while other similar
dendritic cells and macrophages take on this
role adjacent to the bone–implant interface.
Langerhans cells seem to have a greater
antigen-presenting ability when compared to
macrophages in the blood [30, 72]. Due to this,
some believe that the LTT is more useful for
prognosis and diagnosis of metal reactions
when compared to patch testing [73, 74].
Despite this, it is unlikely that the LTT will
replace the patch test as the gold standard and
most commonly clinically used test.
Unfortunately, the LTT is not widely available
for clinical use, is not standardized, has
inter-laboratory variability and is often not
covered by insurance (leading to higher
patient costs). Also, the LTT may produce false
negative results if the test is not transported and
processed in a timely manner. Due to rapid T
cell decay, even short delays can lead to false
negative results [60].
At this time, the scientific literature and
these authors thus favor the skin patch test as
the best available test to evaluate potential
metal hypersensitivity reactions, both prior to
and following implantation. The role of the LTT
remains unclear, but seems to be gaining
support for use in conjunction with the patch
test and potentially coupled with peri-implant
histopathology [60, 67, 75, 76]. Protocols for
patch testing have been proposed based on
implant type and surgical location [60, 77, 78].
One suggested use for the LTT is for further
evaluation of those patients with negative patch
testing and a residual strong clinical suspicion
for metal allergy. In an evaluation of 56 patients
with titanium alloy implants with systemic
symptoms and negative skin patch testing,
54/56 had positive LTT. These 54 had
complete symptom resolution after implant
replacement with a non-titanium device [79].
Another study combined three in vitro assays,
measuring different aspects of lymphocyte
activation in the hope of improving diagnosis
[80]. At this time, more research is needed to
definitively determine the validity and
appropriate clinical use of the LTT [81].
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Post-Implantation Testing
Surprisingly, there is unanimous consensus on
how patients with asymptomatic,
well-functioning devices should be managed:
there is no indication for metal allergy testing.
Management of patients who suffer from
residual post-implantation pain is not as well
defined. It is difficult to ascertain, using patch
testing alone, if a patient truly does suffer from
metal hypersensitivity, and idetermining which
patient would benefit from implant removal/
revision is also challenging. Granchi et al.
concluded that testing is indicated in failed
metal-on-metal temporomandibular joint
replacements with unclear diagnosis [82]. The
assumption is that there exist numerous more
common causes for pain, loosening and/or failure
and that these should be explored prior to
considering metal hypersensitivity as the cause.
These includecomponentmalalignment, complex
regional pain syndrome, crepitation, early aseptic
loosening, infection, instability, patellofemoral
symptoms or patellar clunk syndrome [83]. For
patients who experience residual pain after TKA,
metal hypersensitivity should only be suspected if
the patient had a normal physical exam and
radiographs/CT scans or MARS MRI, and normal
laboratory work-up [83]. An alternative approach
uses clinical findings to identify those with a high
suspicion of metal allergy who may benefit from
metal allergy evaluation [77].
Major diagnostic criteria for
post-implantation metal hypersensitivity
reactions include [78]:
• Eruption overlying the metal implant.
• Positive patch test reaction to a metal used in
the implant.
• Complete recovery after removal of the
offending implant.
• Chronic dermatitis beginning weeks to
months after metallic implantation.
While reactions considered to be less
important are:
• Dermatitis is therapy-resistant.
• Morphology consistent with dermatitis
(erythema, induration, papules, vesicles).
• Systemic allergic dermatitis reaction.
• Histology consistent with allergic contact
dermatitis.
• Positive in vitro test to metals, e.g., the
lymphocyte transformation test.
Paradoxically, to arrive at a definitive
diagnosis of metal allergy, it is necessary for the
patient to undergo complete resolution of
symptoms after device replacement with a
non-allergenic implant. In a similar vein,
Middleton suggests that reaching a definitive
diagnosis of allergy-related implant is
near-impossible, as not only does it require a
show of improvement of clinical symptoms after
implant replacement with an immunologically
inert device but there should also technically be
evidence of typical T-lymphocyte-rich
immunohistopathology and a positive
implant-relevant epicutaneous patch test [44].
While it is promising that the academic
discussion surrounding metal hypersensitivity is
thriving, the conflicting conclusions in the
literature shed insufficient light on pertinent
issues, including but not limited to how patients
who suffer fromchronicpost-surgical pain should
be managed and the extent to which symptoms
may be caused by metal allergy. More studies are
needed before a definitive, evidence-based
algorithm for diagnosis and management can be
generated to tackle the existing dilemma.
CONCLUSION
If an evidence-based approach is desired, there
is only one consensus regarding the morbidity
of metal allergy from implanted devices—there
Dermatol Ther (Heidelb) (2017) 7:53–64 59
is no agreement. In clinical practice, it is a
luxury to have guidelines which are clearly
supported by a body of evidence. Since this is
not the case, patch testing dermatologists,
allergists and the surgeons using the metal
devices need to understand the possible risks
of using an ‘‘allergenic’’ device and
appropriately consent each individual based
on their own history and concerns. A stronger
body of research is needed to clarify the
relationship between metal allergy and
reactions to implanted metal devices. Once a
clear understanding of this relationship is
defined, if it exists, appropriate guidelines can
be drafted in the attempt to clarify management
of or completely avoid allergic reactions to
metal implants.
Some simple conclusions:
• Reactions to metal orthopedic implants do
occur, though rarely, even in those with
metal allergy.
• Routine pre-implant testing in
asymptomatic individuals is not indicated.
• Listen to patient’s concerns about metal
allergy if the concern arises.
• Patch testing is probably the best pre- and
post-implant screening test.
• Post-implantation testing is controversial
and even positive LTT or patch test does
not definitively diagnose morbidity from a
metal allergy. Complete recovery following
revision with an immunologically inert
device is diagnostic.
• More research is needed to scientifically
approach this issue.
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